Cargando…

Convulsive Status Epilepticus in a Cohort of Patients from a Peruvian Academic Hospital

BACKGROUND AND PURPOSE: Status epilepticus is a neurologic emergency whose epidemiology, etiology and management are scarcely known in developing countries. Our objective was to describe the demographic and clinical features as well as the management of generalized convulsive status epilepticus (GCS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bedoya-Sommerkamp, Marcelo, Chau-Rodríguez, Victor Hugo, Medina-Ranilla, Jesús, Escalaya-Advíncula, Alejandro, Ticse-Aguirre, Ray, De La Cruz-Ramírez, Walter, Burneo, Jorge G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Epilepsy Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357561/
https://www.ncbi.nlm.nih.gov/pubmed/34395227
http://dx.doi.org/10.14581/jer.21011
Descripción
Sumario:BACKGROUND AND PURPOSE: Status epilepticus is a neurologic emergency whose epidemiology, etiology and management are scarcely known in developing countries. Our objective was to describe the demographic and clinical features as well as the management of generalized convulsive status epilepticus (GCSE) in adult patients admitted to the emergency department of an academic hospital in Peru, between March 2019 and March 2020. METHODS: Observational study of a prospective cohort in which patients were assessed by the emergency and neurology department on the first day of hospitalization, at discharge and at 30 days post-discharge in a follow-up visit. Relevant demographics and clinical data were collected. After being encoded and sorted, univariate statistical analysis was carried out. RESULTS: Of the sample of 59 patients, 62.7% were males, 57.6% were unemployed, 89.8% did not finish high school, and 55.9% had intermittent GCSE with no seizure at arrival. The total calculated median times were: 60 minutes from GCSE onset to hospital arrival, 110 minutes from GCSE onset to 1st line therapy, and 7 minutes from hospital arrival to 1st line therapy. The most frequently used antiepileptic drugs were one dose of benzodiazepine (41.7%), phenytoin (76.9%), and additional doses of benzodiazepines (60%) for 1st, 2nd, and 3rd line therapies, respectively. The most frequent etiologies were antiepileptic drug suspension (27.1%), undetermined (25.4%) and acute stroke (11.8%). 62.71% had 0–2 modified Rankin score at discharge. CONCLUSIONS: In this cohort of patients, GCSE was mainly intermittent. Management times differed from the guidelines’ recommendations.